ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array

$ 19.99

4.8
(387)
In stock
Description

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint

Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain Monitoring Platform

Jacqueline Keller on LinkedIn: Welcome! You are invited to join a webinar: Data Driven Evolution of…

ClearPoint Neuro, Inc. on LinkedIn: #clearpoint #smartflow #clpt #genetherapy #clinicaltrials

As part of Cancer Moonshot, FDA seeks to prohibit menthol cigarettes, flavored cigars - The Cancer Letter

ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions - Simply Wall St

ClearPoint neuro (CLPT) - Biotek - TekInvestor - Norges Beste Aksjeforum

Jacqueline Keller on LinkedIn: #clpt #nsgy

ClearPoint Neuro, Inc. on LinkedIn: #clearpoint #nsgy #clpt

ClearPoint Neuro, Inc.

Initial Clinical Experience With ClearPoint SmartFrame Array–Aided Stereotactic Procedures - ScienceDirect

Issue 17 - The Cancer Letter

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System